Fundies.
English

Segment disclosures

Company overview

AVANOS MEDICAL, INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

8 dimension combinations 109 retained observations 33 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Medical Devices

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=avns:MedicalDevicesMember
PeriodValueUnitFiledEvidence
2018-04-01 – 2018-06-30160900000 USD20180807Open filing evidence
2018-01-01 – 2018-06-30317300000 USD20180807Open filing evidence
2017-04-01 – 2017-06-30149100000 USD20180807Open filing evidence
2017-01-01 – 2017-06-30294800000 USD20180807Open filing evidence

Operating Segments · Pain Management And Recovery

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=avns:PainManagementAndRecoveryMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-3156300000 USD20260505Open filing evidence
2025-01-01 – 2025-12-31237800000 USD20260224Open filing evidence
2025-07-01 – 2025-09-3059000000 USD20251105Open filing evidence
2025-01-01 – 2025-09-30176200000 USD20251105Open filing evidence
2025-04-01 – 2025-06-3061000000 USD20250805Open filing evidence
2025-01-01 – 2025-06-30117200000 USD20250805Open filing evidence
2025-01-01 – 2025-03-3156200000 RestatedUSD20260505Open filing evidence
2024-01-01 – 2024-12-31234200000 USD20260224Open filing evidence
2024-07-01 – 2024-09-3057800000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30173400000 USD20251105Open filing evidence
2024-04-01 – 2024-06-3059300000 USD20250805Open filing evidence
2024-01-01 – 2024-06-30115600000 USD20250805Open filing evidence
2024-01-01 – 2024-03-3156300000 USD20250506Open filing evidence
2023-01-01 – 2023-12-31227300000 USD20260224Open filing evidence

Operating Segments · Specialty Nutrition Systems

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=avns:SpecialtyNutritionSystemsMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-31124000000 USD20260505Open filing evidence
2025-01-01 – 2025-12-31432900000 USD20260224Open filing evidence
2025-07-01 – 2025-09-30114000000 USD20251105Open filing evidence
2025-01-01 – 2025-09-30317800000 USD20251105Open filing evidence
2025-04-01 – 2025-06-30102700000 USD20250805Open filing evidence
2025-01-01 – 2025-06-30203800000 USD20250805Open filing evidence
2025-01-01 – 2025-03-31101100000 USD20260505Open filing evidence
2024-01-01 – 2024-12-31396400000 USD20260224Open filing evidence
2024-07-01 – 2024-09-3098200000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30290500000 USD20251105Open filing evidence
2024-04-01 – 2024-06-3097700000 USD20250805Open filing evidence
2024-01-01 – 2024-06-30192300000 USD20250805Open filing evidence
2024-01-01 – 2024-03-3194600000 USD20250506Open filing evidence
2023-01-01 – 2023-12-31371600000 USD20260224Open filing evidence

Operating Segments · Corporate And Other

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:CorporateAndOtherMember
PeriodValueUnitFiledEvidence
2026-01-01 – 2026-03-311900000 USD20260505Open filing evidence
2025-01-01 – 2025-12-3130500000 USD20260224Open filing evidence
2025-07-01 – 2025-09-304800000 USD20251105Open filing evidence
2025-01-01 – 2025-09-3026300000 USD20251105Open filing evidence
2025-04-01 – 2025-06-3011300000 USD20250805Open filing evidence
2025-01-01 – 2025-06-3021500000 USD20250805Open filing evidence
2025-01-01 – 2025-03-3110200000 RestatedUSD20260505Open filing evidence
2024-01-01 – 2024-12-3157200000 USD20260224Open filing evidence
2024-07-01 – 2024-09-3014400000 USD20251105Open filing evidence
2024-01-01 – 2024-09-3044300000 USD20251105Open filing evidence
2024-04-01 – 2024-06-3014700000 USD20250805Open filing evidence
2024-01-01 – 2024-06-3029900000 USD20250805Open filing evidence
2024-01-01 – 2024-03-3115200000 USD20250506Open filing evidence
2023-01-01 – 2023-12-3174400000 USD20260224Open filing evidence

Operating Segments · Medical Devices

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hyh:MedicalDevicesMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-03-31156400000 USD20180502Open filing evidence
2017-01-01 – 2017-12-31611600000 USD20180227Open filing evidence
2017-07-01 – 2017-09-30150700000 USD20171101Open filing evidence
2017-01-01 – 2017-09-30445700000 USD20171101Open filing evidence
2017-04-01 – 2017-06-30149100000 USD20170802Open filing evidence
2017-01-01 – 2017-06-30295000000 USD20170802Open filing evidence
2017-01-01 – 2017-03-31145700000 RestatedUSD20180502Open filing evidence
2016-01-01 – 2016-12-31566200000 RestatedUSD20180227Open filing evidence
2016-07-01 – 2016-09-30145200000 USD20171101Open filing evidence
2016-01-01 – 2016-09-30413400000 USD20171101Open filing evidence
2016-04-01 – 2016-06-30141500000 USD20170802Open filing evidence
2016-01-01 – 2016-06-30268200000 USD20170802Open filing evidence
2016-01-01 – 2016-03-31126700000 USD20170502Open filing evidence
2015-01-01 – 2015-12-31509000000 RestatedUSD20180227Open filing evidence
2015-07-01 – 2015-09-30126100000 USD20161103Open filing evidence
2015-01-01 – 2015-09-30375300000 USD20161103Open filing evidence
2015-04-01 – 2015-06-30126900000 USD20160805Open filing evidence
2015-01-01 – 2015-06-30249200000 USD20160805Open filing evidence
2015-01-01 – 2015-03-31122300000 USD20160509Open filing evidence
2014-01-01 – 2014-12-31501700000 USD20170227Open filing evidence
2014-07-01 – 2014-09-30122500000 USD20151104Open filing evidence
2014-01-01 – 2014-09-30373500000 USD20151104Open filing evidence
2014-04-01 – 2014-06-30121400000 USD20150812Open filing evidence
2014-01-01 – 2014-06-30251000000 USD20150812Open filing evidence
2014-01-01 – 2014-03-31129600000 USD20150722Open filing evidence
2013-01-01 – 2013-12-31499000000 USD20160229Open filing evidence
2013-07-01 – 2013-09-30126200000 USD20141120Open filing evidence
2013-01-01 – 2013-09-30366800000 USD20141120Open filing evidence
2012-01-01 – 2012-12-31477600000 USD20150722Open filing evidence

Operating Segments · Surgicaland Infection Prevention

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=hyh:SurgicalandInfectionPreventionMember
PeriodValueUnitFiledEvidence
2017-07-01 – 2017-09-30246100000 USD20171101Open filing evidence
2017-01-01 – 2017-09-30740000000 USD20171101Open filing evidence
2017-04-01 – 2017-06-30246500000 USD20170802Open filing evidence
2017-01-01 – 2017-06-30493900000 USD20170802Open filing evidence
2017-01-01 – 2017-03-31247400000 USD20170502Open filing evidence
2016-01-01 – 2016-12-311012100000 USD20170227Open filing evidence
2016-07-01 – 2016-09-30248800000 USD20171101Open filing evidence
2016-01-01 – 2016-09-30760200000 USD20171101Open filing evidence
2016-04-01 – 2016-06-30256700000 USD20170802Open filing evidence
2016-01-01 – 2016-06-30511400000 USD20170802Open filing evidence
2016-01-01 – 2016-03-31254700000 USD20170502Open filing evidence
2015-01-01 – 2015-12-311030200000 USD20170227Open filing evidence
2015-07-01 – 2015-09-30257400000 USD20161103Open filing evidence
2015-01-01 – 2015-09-30767500000 USD20161103Open filing evidence
2015-04-01 – 2015-06-30255300000 USD20160805Open filing evidence
2015-01-01 – 2015-06-30510100000 USD20160805Open filing evidence
2015-01-01 – 2015-03-31254800000 USD20160509Open filing evidence
2014-01-01 – 2014-12-311139300000 USD20170227Open filing evidence
2014-07-01 – 2014-09-30279200000 USD20151104Open filing evidence
2014-01-01 – 2014-09-30840200000 USD20151104Open filing evidence
2014-04-01 – 2014-06-30285500000 USD20150812Open filing evidence
2014-01-01 – 2014-06-30561000000 USD20150812Open filing evidence
2014-01-01 – 2014-03-31275500000 USD20150722Open filing evidence
2013-01-01 – 2013-12-311153100000 USD20160229Open filing evidence
2013-07-01 – 2013-09-30287000000 USD20141120Open filing evidence
2013-01-01 – 2013-09-30860100000 USD20141120Open filing evidence
2012-01-01 – 2012-12-311185100000 USD20150722Open filing evidence

Medical Devices · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=avns:MedicalDevicesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2018-07-01 – 2018-09-30165100000 USD20181217Open filing evidence
2018-01-01 – 2018-09-30482400000 USD20181217Open filing evidence
2017-07-01 – 2017-09-30150500000 USD20181217Open filing evidence
2017-01-01 – 2017-09-30445300000 USD20181217Open filing evidence

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=avns:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-31687800000 USD20250226Open filing evidence
2023-01-01 – 2023-12-31673300000 USD20250226Open filing evidence
2022-01-01 – 2022-12-31684100000 USD20250226Open filing evidence